Keybank National Association OH Decreases Position in Genpact Limited (NYSE:G)

Keybank National Association OH lowered its stake in shares of Genpact Limited (NYSE:G) by 3.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 9,853 shares of the business services provider’s stock after selling 311 shares during the quarter. Keybank National Association OH’s holdings in Genpact were worth $382,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Squar Milner Financial Services LLC raised its position in shares of Genpact by 370.1% during the 3rd quarter. Squar Milner Financial Services LLC now owns 677 shares of the business services provider’s stock valued at $26,000 after buying an additional 533 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Genpact during the second quarter worth about $31,000. Captrust Financial Advisors boosted its stake in Genpact by 109.8% during the second quarter. Captrust Financial Advisors now owns 1,072 shares of the business services provider’s stock worth $41,000 after acquiring an additional 561 shares in the last quarter. Lindbrook Capital LLC boosted its stake in Genpact by 195.3% during the third quarter. Lindbrook Capital LLC now owns 1,193 shares of the business services provider’s stock worth $46,000 after acquiring an additional 789 shares in the last quarter. Finally, Capital Bank & Trust Co bought a new stake in Genpact during the second quarter worth about $78,000. Institutional investors own 95.57% of the company’s stock.

Shares of NYSE G traded up $0.45 during midday trading on Friday, hitting $40.73. The stock had a trading volume of 135,813 shares, compared to its average volume of 1,116,812. The business’s 50 day moving average is $38.78 and its 200-day moving average is $38.51. The company has a market cap of $7.55 billion, a P/E ratio of 25.46, a PEG ratio of 2.09 and a beta of 0.79. Genpact Limited has a 52 week low of $25.48 and a 52 week high of $44.55. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.77.

Genpact (NYSE:G) last issued its earnings results on Thursday, November 7th. The business services provider reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.04. The firm had revenue of $888.80 million for the quarter, compared to the consensus estimate of $884.91 million. Genpact had a net margin of 8.84% and a return on equity of 21.42%. The business’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.48 earnings per share. As a group, analysts expect that Genpact Limited will post 1.7 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Monday, December 9th will be paid a $0.085 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $0.34 annualized dividend and a dividend yield of 0.83%. Genpact’s dividend payout ratio is presently 21.25%.

In other news, SVP Balkrishan Kalra sold 30,200 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $40.27, for a total transaction of $1,216,154.00. Following the completion of the transaction, the senior vice president now directly owns 164,216 shares of the company’s stock, valued at $6,612,978.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last quarter, insiders sold 77,720 shares of company stock worth $3,152,168. Insiders own 1.86% of the company’s stock.

Several equities research analysts recently commented on G shares. Deutsche Bank boosted their price objective on shares of Genpact from $36.00 to $44.00 and gave the stock a “hold” rating in a research note on Thursday, August 8th. Zacks Investment Research raised shares of Genpact from a “sell” rating to a “hold” rating and set a $43.00 price objective on the stock in a research note on Thursday, September 12th. ValuEngine lowered shares of Genpact from a “buy” rating to a “hold” rating in a research note on Friday, September 27th. Needham & Company LLC reissued a “buy” rating and set a $48.00 price objective on shares of Genpact in a research note on Friday, November 8th. Finally, Cantor Fitzgerald boosted their price objective on shares of Genpact from $40.00 to $47.00 and gave the stock an “overweight” rating in a research note on Thursday, August 8th. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $40.18.

About Genpact

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

Featured Story: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.